Tower Research Capital (TRC)’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-458
| Closed | -$60K | – | 6041 |
|
2020
Q4 | $60K | Sell |
458
-170
| -27% | -$22.3K | ﹤0.01% | 2926 |
|
2020
Q3 | $32K | Sell |
628
-1,042
| -62% | -$53.1K | ﹤0.01% | 3711 |
|
2020
Q2 | $80K | Buy |
+1,670
| New | +$80K | ﹤0.01% | 2651 |
|
2019
Q4 | – | Sell |
-512
| Closed | -$18K | – | 4772 |
|
2019
Q3 | $18K | Buy |
+512
| New | +$18K | ﹤0.01% | 2560 |
|
2019
Q1 | – | Sell |
-2,325
| Closed | -$32K | – | 4582 |
|
2018
Q4 | $32K | Buy |
2,325
+247
| +12% | +$3.4K | ﹤0.01% | 1600 |
|
2018
Q3 | $21K | Buy |
+2,078
| New | +$21K | ﹤0.01% | 2326 |
|